Elevance Health, Inc. 13F holders
Of the 44 funds followed here, 12 reported a position in Elevance Health, Inc. in a 13F for the quarter ended 30 June 2026. The largest: Geode Capital Management, 5.2 million shares worth $1.99 billion, 0.1% of its reported book. Sold out: Capital Research Global Investors.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Geode Capital Management | 5,166,124 | $1.99 billion | 0.1% | -26,583 | trimmed | 30 June 2026 | 13F |
| Harris Associates | 4,924,511 | $1.90 billion | 2.5% | -212,015 | trimmed | 30 June 2026 | 13F |
| Norges Bank | 3,958,856 | $1.53 billion | 0.2% | held | 30 June 2026 | 13F | |
| FMR LLC | 3,131,652 | $1.21 billion | 0.1% | +1,155,933 | added | 30 June 2026 | 13F |
| Citadel Advisors | 1,284,486 | $496.7 million | 0.1% | -610,333 | trimmed | 30 June 2026 | 13F |
| Baillie Gifford | 1,083,237 | $418.9 million | 0.4% | -89,571 | trimmed | 30 June 2026 | 13F |
| Millennium Management | 836,861 | $323.6 million | 0.1% | -131,510 | trimmed | 30 June 2026 | 13F |
| Renaissance Technologies | 201,373 | $77.9 million | 0.1% | +185,800 | added | 30 June 2026 | 13F |
| Alyeska | 173,839 | $67.2 million | 0.2% | +98,839 | added | 30 June 2026 | 13F |
| Two Sigma Investments | 166,161 | $64.3 million | 0.0% | +163,901 | added | 30 June 2026 | 13F |
| Point72 Asset Management | 67,300 | $26.0 million | 0.0% | -18,141 | trimmed | 30 June 2026 | 13F |
| Dodge & Cox | 1,300 | $502,749 | 0.0% | no change | held | 30 June 2026 | 13F |
| Capital Research Global Investors | 0 | $0 | 0.0% | -119,078 | exited | 30 June 2026 | 13F |
Value is what the fund reported. Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.
Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 29 April 2026 | 13G | Vanguard Capital Management and 1 other | 16.6 million | 7.1% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 26 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder. Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.
Fails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 24 August 2026 | 1,100 | $400.54 | SEC |
| 4 August 2026 | 1,635 | $382.77 | SEC |
| 3 August 2026 | 5,331 | $375.84 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period. Largest in the window: 5,331 on 3 August 2026. A fail is an operational fact about settlement, not a position.
Source
Each fund's 13F-HR on EDGAR, linked per row; positions matched to ELV by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.